Ming Lv

853 total citations
46 papers, 691 citations indexed

About

Ming Lv is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ming Lv has authored 46 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Immunology. Recurrent topics in Ming Lv's work include Monoclonal and Polyclonal Antibodies Research (7 papers), RNA Interference and Gene Delivery (5 papers) and Cell death mechanisms and regulation (5 papers). Ming Lv is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), RNA Interference and Gene Delivery (5 papers) and Cell death mechanisms and regulation (5 papers). Ming Lv collaborates with scholars based in China, Japan and United States. Ming Lv's co-authors include Jiannan Feng, Bing Shen, Jing Wang, Jiyan Zhang, Xinying Li, Chunxia Qiao, Qingyang Wang, Zhongxue Wu, Liqian Sun and Manman Zhao and has published in prestigious journals such as Hepatology, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Ming Lv

46 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ming Lv China	17	369	125	116	107	92	46	691
Jeong Yoon Song South Korea	10	286 0.8×	195 1.6×	143 1.2×	48 0.4×	74 0.8×	21	570
Yu Geng China	16	386 1.0×	130 1.0×	113 1.0×	103 1.0×	107 1.2×	20	684
Michi Tanaka Japan	14	232 0.6×	94 0.8×	107 0.9×	147 1.4×	40 0.4×	25	959
Shuyu Li China	15	359 1.0×	116 0.9×	140 1.2×	141 1.3×	112 1.2×	35	771
Kristine Misund Norway	20	669 1.8×	146 1.2×	205 1.8×	124 1.2×	72 0.8×	50	986
Zheng Jiang China	19	527 1.4×	211 1.7×	171 1.5×	111 1.0×	171 1.9×	36	974
Jun Zheng China	15	310 0.8×	174 1.4×	109 0.9×	56 0.5×	53 0.6×	45	593
Sarah Yoon South Korea	15	574 1.6×	286 2.3×	180 1.6×	118 1.1×	146 1.6×	22	918
Fei Chu United States	16	574 1.6×	181 1.4×	381 3.3×	119 1.1×	125 1.4×	34	1.1k

Countries citing papers authored by Ming Lv

Since Specialization

Citations

This map shows the geographic impact of Ming Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Lv more than expected).

Fields of papers citing papers by Ming Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Lv. The network helps show where Ming Lv may publish in the future.

Co-authorship network of co-authors of Ming Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Lv. A scholar is included among the top collaborators of Ming Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Lv. Ming Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lv, Ming, Handong Yang, Wenwen Wu, et al.. (2025). The clinical significance of T-cell regulation in hypertension treatment. PubMed. 16. 1550206–1550206. 2 indexed citations

Xiao, Guangxu, Yuhan Zhao, Hongying Du, et al.. (2023). Guanxinning injection ameliorates cardiac remodeling in HF mouse and 3D heart spheroid models via p38/FOS/MMP1-mediated inhibition of myocardial hypertrophy and fibrosis. Biomedicine & Pharmacotherapy. 162. 114642–114642. 20 indexed citations

Wei, Qi, et al.. (2022). Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients. Investigational New Drugs. 40(4). 818–830. 14 indexed citations

Wei, Qi, et al.. (2021). Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes. Pathology & Oncology Research. 27. 1609782–1609782. 14 indexed citations

Duan, Yanting, Longlong Luo, Chunxia Qiao, et al.. (2019). A novel human anti‐AXL monoclonal antibody attenuates tumour cell migration. Scandinavian Journal of Immunology. 90(2). e12777–e12777. 23 indexed citations

Huang, Qin, Ming Lv, Xiaofang He, et al.. (2018). Low Concentrations of Caffeine and Its Analogs Extend the Lifespan of Caenorhabditis elegans by Modulating IGF-1-Like Pathway. Frontiers in Aging Neuroscience. 10. 211–211. 15 indexed citations

Liu, Changjun, Ming Lv, Zongyun Chen, et al.. (2016). Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses, and Treponema pallidum infections among blood donors at Shiyan, Central China. BMC Infectious Diseases. 16(1). 531–531. 24 indexed citations

Chen, Jingrui, Wenjie Cao, Ming Lv, et al.. (2016). Amelioration of cardiac dysfunction and ventricular remodeling after myocardial infarction by danhong injection are critically contributed by anti-TGF-β-mediated fibrosis and angiogenesis mechanisms. Journal of Ethnopharmacology. 194. 559–570. 48 indexed citations

Zhu, Ting, et al.. (2015). Neddylation controls basal MKK7 kinase activity in breast cancer cells. Oncogene. 35(20). 2624–2633. 17 indexed citations

10.

Zhao, Lei, et al.. (2015). Therapeutic effect of lymphokine-activated killer cells treated with low-dose ionizing radiation on osteosarcoma. Oncology Letters. 10(2). 879–882. 3 indexed citations

11.

Wang, Qun, Jing Yang, Tang Kun, et al.. (2014). Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization. BMC Biotechnology. 14(1). 17–17. 13 indexed citations

12.

Yang, Jing, Qun Wang, Chunxia Qiao, et al.. (2014). Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60. Cellular and Molecular Immunology. 11(3). 285–293. 22 indexed citations

13.

Luo, Longlong, Qun Luo, Leiming Guo, et al.. (2013). Structure-based affinity maturation of a chimeric anti-ricin antibody C4C13. Journal of Biomolecular Structure and Dynamics. 32(3). 416–423. 6 indexed citations

14.

Guo, Yuanyuan, Wendie Wang, Jing Wang, et al.. (2012). Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity. Hepatology. 57(1). 140–151. 57 indexed citations

15.

Hu, Yi, Chunxia Qiao, Ming Lv, et al.. (2012). Arg9 facilitates the translocation and downstream signal inhibition of an anti-HER2 single chain antibody. BMC Research Notes. 5(1). 336–336. 3 indexed citations

16.

Qiao, Chunxia, Ming Lv, Lin Zhou, et al.. (2012). Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation. BMC Immunology. 13(1). 40–40. 1 indexed citations

17.

Wang, Jing, Ming Lv, Qingyang Wang, et al.. (2010). Defective anchoring of JNK1 in the cytoplasm by MKK7 in Jurkat cells is associated with resistance to Fas-mediated apoptosis. Molecular Biology of the Cell. 22(1). 117–127. 16 indexed citations

18.

Cui, Jian, Qingyang Wang, Jing Wang, et al.. (2009). Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells. Molecular Cancer Therapeutics. 8(12). 3214–3222. 40 indexed citations

19.

Wang, Jing, Lin Zhou, Ming Lv, et al.. (2008). Characterization of a Novel Anti-DR5 Monoclonal Antibody WD1 with the Potential to Induce Tumor Cell Apoptosis. Cellular and Molecular Immunology. 5(1). 55–60. 7 indexed citations

20.

Xia, Qing, Hongxia Wang, Jie Wang, et al.. (2005). Proteomic analysis of interleukin 6-induced differentiation in mouse myeloid leukemia cells. The International Journal of Biochemistry & Cell Biology. 37(6). 1197–1207. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact